Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkermes plc. Director's Dealing 2011

Sep 20, 2011

31048_dirs_2011-09-20_04e4fa67-e7f1-4770-9b96-3442d571bb7c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16

Reporting Person: POPS RICHARD F (Director, Director and CEO, Alkermes plc)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-16 Common Stock A 424354 Acquired 424354 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-16 Employee Stock Option (Right to Buy) $8.55 A 220000 Acquired 2019-05-26 Common Stock (220000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $9.21 A 500000 Acquired 2019-11-18 Common Stock (500000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $12.29 A 170000 Acquired 2018-05-27 Common Stock (170000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $14.13 A 50000 Acquired 2017-11-05 Common Stock (50000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $11.74 A 325000 Acquired 2020-05-17 Common Stock (325000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $18.105 A 400000 Acquired 2021-05-20 Common Stock (400000) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $4.77 A 20968 Acquired 2012-07-18 Common Stock (20968) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $9.97 A 10030 Acquired 2013-04-25 Common Stock (10030) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.30 A 8130 Acquired 2014-07-12 Common Stock (8130) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $15.95 A 6269 Acquired 2017-06-01 Common Stock (6269) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $18.60 A 5376 Acquired 2015-12-09 Common Stock (5376) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $19.40 A 5155 Acquired 2011-10-02 Common Stock (5155) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $20.79 A 4810 Acquired 2016-05-02 Common Stock (4810) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $4.77 A 104032 Acquired 2012-07-18 Common Stock (104032) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $7.36 A 350000 Acquired 2012-12-12 Common Stock (350000) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $9.97 A 156220 Acquired 2013-04-25 Common Stock (156220) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.16 A 184125 Acquired 2013-12-10 Common Stock (184125) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.30 A 141870 Acquired 2014-07-12 Common Stock (141870) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.38 A 120000 Acquired 2016-12-12 Common Stock (120000) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.57 A 149625 Acquired 2013-10-17 Common Stock (149625) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.90 A 350000 Acquired 2014-12-17 Common Stock (350000) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $15.95 A 93731 Acquired 2017-06-01 Common Stock (93731) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $18.60 A 182124 Acquired 2015-12-09 Common Stock (182124) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $19.40 A 244845 Acquired 2011-10-02 Common Stock (244845) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $20.79 A 88940 Acquired 2016-05-02 Common Stock (88940) Direct
2011-09-16 Restricted Stock Award $0 A 250000 Acquired Common Stock (250000) Direct
2011-09-16 Restricted Stock Award $0 A 25000 Acquired 2014-05-26 Common Stock (25000) Direct
2011-09-16 Restricted Stock Unit Award $0 A 24375 Acquired Common Stock (24375) Direct
2011-09-16 Restricted Stock Unit Award $0 A 32500 Acquired Common Stock (32500) Direct

Footnotes

F1: 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.

F2: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.

F3: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 11/18/11.

F4: 75% vested as of 9/16/11, remainder vests on 5/27/12.

F5: 75% vested as of 9/16/11, remainder vests on 11/5/11.

F6: 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 5/17/12.

F7: Vests in 4 equal annual installments beginning on 5/20/12.

F8: These options are fully vested in accordance with their terms.

F9: 50% vests on 11/18/12 and 50% vests on 11/18/13.

F10: Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.

F11: Performance-based restricted stock unit award. Commencing on 5/26/10, a determination will be made if the performance criteria have been met. Shares subject to the award vest in full upon the achievement of the performance criteria. If such performance criteria have not been met within a period of five years from the date of grant, all of the shares subject to the award are forfeited.

F12: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.